Physician profile
Raul Franceschi
NPI 1770558595
$2,394.89
in general payments reported to CMS, 2019-2025
12 companies · $76.42 in 2025
The $76.42 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $12.76 · 2021: $245 · 2022: $476 · 2023: $592 · 2024: $403 · 2025: $76.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.05 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $827.36 | 2019-2024 | Eylea Hd |
| Genentech USA, INC. | $488.17 | 2022-2025 | Vabysmo |
| Alcon Puerto Rico INC | $319.88 | 2019-2023 | Clareon |
| Bausch & Lomb Americas INC. | $272.87 | 2022-2025 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Apellis Pharmaceuticals, INC. | $148.05 | 2023-2024 | Syfovre |
| Mallinckrodt Hospital Products INC. | $92.99 | 2021 | |
| Abbvie INC. | $53.01 | 2023 | |
| Alcon Vision LLC | $51.93 | 2024 | Clareon |
| Allergan, INC. | $44.37 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $38.56 | 2022-2023 | |
| Carl Zeiss Meditec USA, INC. | $33.78 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.92 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Franceschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.